Showing 1 - 13 results of 13 for search 'Antònia Agustí', query time: 0.04s
Refine Results
-
1
-
2
-
3
Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review by Carla Sans-Pola, Carla Sans-Pola, Carla Sans-Pola, Immaculada Danés, Immaculada Danés, Immaculada Danés, Josep Àngel Bosch, Patricia Marrero-Álvarez, Josefina Cortés, Antònia Agustí, Antònia Agustí, Antònia Agustí
Published 2023-05-01
Article -
4
Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system by Francesca Filippi-Arriaga, Cristina Aguilera, Cristina Aguilera, Cristina Aguilera, Elena Guillén, Elena Guillén, Lucía Bellas, Eulàlia Pérez, Lourdes Vendrell, Antònia Agustí, Antònia Agustí, Antònia Agustí, Gloria Cereza, Gloria Cereza
Published 2023-07-01
Article -
5
-
6
-
7
-
8
Safety of Drugs Used during the First Wave of COVID-19: A Hospital-Registry-Based Study by Cristina Aguilera, Immaculada Danés, Elena Guillén, Alba Vimes, Montserrat Bosch, Gloria Cereza, Adrián Sánchez-Montalvá, Isabel Campos-Varela, Marta Miarons, Jaume Mestre-Torres, Antònia Agustí
Published 2022-07-01
Article -
9
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice by Mònica Sabaté Gallego, Mònica Sabaté Gallego, Eulàlia Pérez Esquirol, Núria Garcia Doladé, Xavier Vidal Guitart, Xavier Vidal Guitart, Maria-Josep Carreras Soler, Anna Farriols Danés, Enriqueta Felip, Enriqueta Felip, Irene Braña, Irene Braña, Joan Carles Galceran, Joan Carles Galceran, Rafael Morales Barrera, Rafael Morales Barrera, Eva Muñoz-Couselo, Eva Muñoz-Couselo, Antònia Agustí Escasany, Antònia Agustí Escasany
Published 2022-08-01
Article -
10
Características del uso inadecuado de medicamentos en pacientes pluripatológicos de edad avanzada by Paula Carlota Rivas-Cobas, Nieves Ramírez-Duque, Mercedes Gómez Hernández, Juana García, Antonia Agustí, Xavier Vidal, Francesc Formiga, Alfonso López-Soto, Olga H. Torres, Antonio San-José
Published 2017-07-01
Article -
11
Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection by Oleguer Parés-Badell, Xavier Martínez-Gómez, Laia Pinós, Blanca Borras-Bermejo, Sonia Uriona, Susana Otero-Romero, José Ángel Rodrigo-Pendás, Yolima Cossio-Gil, Antònia Agustí, Cristina Aguilera, Magda Campins
Published 2021-12-01
Article -
12
Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination by Oleguer Parés-Badell, Ricardo Zules-Oña, Lluís Armadans, Laia Pinós, Blanca Borrás-Bermejo, Susana Otero, José Ángel Rodrigo-Pendás, Martí Vivet-Escalé, Yolima Cossio-Gil, Antònia Agustí, Cristina Aguilera, Magda Campins, Xavier Martínez-Gómez
Published 2022-07-01
Article -
13
Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study by Javier García-Pérez, María González-Pérez, María Castillo de la Osa, Alberto M. Borobia, Luis Castaño, María Jesús Bertrán, Magdalena Campins, Antonio Portolés, David Lora, Mercedes Bermejo, Patricia Conde, Lourdes Hernández-Gutierrez, Antonio Carcas, Eunate Arana-Arri, Marta Tortajada, Inmaculada Fuentes, Ana Ascaso, María Teresa García-Morales, Humberto Erick de la Torre-Tarazona, José-Ramón Arribas, Natale Imaz-Ayo, Eugènia Mellado-Pau, Antonia Agustí, Carla Pérez-Ingidua, Agustín Gómez de la Cámara, Jordi Ochando, Cristobal Belda-Iniesta, Jesús Frías, José Alcamí, Mayte Pérez-Olmeda
Published 2022-08-01
Article